Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease

Packets of Wegovy at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that will intensify competition. Photographer: Bloomberg/Bloomberg

Leave a Comment